Clinical Trial Update: Safety and Efficacy of Positron Emission Tomography (PET) Imaging With MNI-558 [EARLY_Phase 1]

View source ↗

Summary

This early-phase study reports initial safety and imaging efficacy data for the PET radioligand MNI-558 in Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• MNI-558

Snippet

Sponsor: Institute for Neurodegenerative Disorders | Conditions: Alzheimer Disease | EARLY_Phase 1 | Status: COMPLETED